[cancerpage is a service of Alere]
 


[home]
[search the site]
[my cancerpage]
[ribbon project]
[stories and experiences]
[glossary of terms]
[journal of hope]
[comments]
[about us]
[policies and disclaimers]
[physician and service directories]

Family Cancer History Boosts Risk for Hodgkin"s Lymphoma Survivors

By David Douglas

NEW YORK MAR 31, 2008 (Reuters Health) - People who survive Hodgkin"s lymphoma (HL) but have a family history of cancer are at greater risk for a second primary malignancy, according to Swedish researchers.

In the March issue of the British Journal of Cancer, Dr. Anne Andersson of Umea University Hospital and colleagues note that although there has been an increase in long-term survival after HL, life expectancy is still shorter than normal, in part due to a high risk of second malignancies.

To study the influence of a family history of cancer on survival, the researchers examined Swedish Cancer Registry data on 6946 patients treated for HL between 1965 and 1995. Altogether, 1453 HL patients (20.9%) had one or more first-degree relatives with a history of cancer.

Second malignancies developed in 696 (15%) HL patients a year or more after the original diagnosis. The risk of a second cancer increased with the number of first degree relatives with cancer.

The standardized incidence ratio (SIR) for patients with no family history of cancer was 2.06. With one relative with cancer, the SIR rose to 3.01, and with two or more, it was 3.45.

Dr. Andersson told Reuters Health that the increased risk for secondary cancers among survivors of HL "may be due to gene-environment interaction."

"A family history of cancer," she added, "could be one of the factors to consider when setting up surveillance programs for this group of patients."

SOURCE:

  • Br J Cancer 2008;98:1001-1005.



  • "Reuters content is the intellectual property of Reuters Limited. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon."
     

     MedlinePlus is a resource for health information offered to the public by the US Government. The search box below will direct you to publicly available health information from the National Institutes of Health, the FDA and other government agencies.
    Search MEDLINEplus:
     

    MEDLINEplus en español

     
    We subscribe to the HONcode principles of the Health On the Net Foundation


    cancerpage.com 2000
    - 2009 . Please send your feedback, comments and suggestions to our staff. Read our policies and terms of service . cancerpage.com is a service of Alere® .
    © (2009) Inverness Medical. All Rights Reserved. Alere is a trademark of the Inverness Medical group of companies.